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Cardiology, Erasmus University Medical Center, Rotterdam, the NetherlandsBackground. Orthotopic heart transplantation (OHT) is
the gold standard treatment in end-stage heart disease.
Controversy remains whether bicaval OHT is superior to
biatrial OHT in both early and late outcomes. This study
aimed toprovideanoverviewof theearly and lateoutcomes
in patients who underwent a bicaval or biatrial OHT.
Methods. A systematic literature search was performed
for articles published before December 2017. Studies
comparing adult patients undergoing biatrial OHT and
bicaval OHT were included. Early outcomes were pooled
in odds ratios and late outcomes were pooled in rate ra-
tios. Late survival was visualized by a pooled Kaplan-
Meier curve.
Results. A total of 36 publications were included in the
meta-analysis, counting 3555 patients undergoing biatrial
OHT and 3208 patients undergoing bicaval OHT. Early
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Published by Elsevier Inc.regurgitation, and permanent pacemaker implantation
differed significantly in favor of the bicaval OHT
patients. Long-term survival was significantly better in
patients undergoing bicaval vs biatrial OHT (hazard ra-
tio, 1.32; 95% confidence interval, 1.1-1.6; P [ .008). Also,
late tricuspid regurgitation was less frequently seen in
the bicaval OHT patients (rate ratio, 2.14; 95% CI, 1.17-
3.94; P ¼ .014).
Conclusions. This systematic review with meta-
analysis shows that bicaval OHT results in more favor-
able early and late outcomes for patients undergoing a
bicaval OHT compared with a biatrial OHT. Therefore,
bicaval OHT should be considered as preferable tech-
nique for OHT.
(Ann Thorac Surg 2020;-:---)
 2020 by The Society of Thoracic Surgeonsrthotopic heart transplantation (OHT) remains theOgold standard for patients with end-stage heart
failure.1 The standard biatrial OHT technique was intro-
duced by Lower and Shumway in 19602 and is still widely
used because of its relative simplicity. This technique
only requires 2 anastomoses to the atria of the recipient.
Yacoub and colleagues3 introduced the bicaval OHT
technique in 1989, and it has gained popularity since. The
bicaval technique requires a single left atrial anastomosis
and separate caval suture lines. However, controversy
regarding the preferred surgical OHT technique remains.
There is a broad variety of studies that describe potential
differences in outcome between the 2 surgical techniques.
The biatrial technique tends to be less technical chal-
lenging for cardiac implantation, which results in areduced ischemic time of the allograft.4,5 However, the
biatrial technique is known for worse hemodynamics
because of the redundant atrial tissue and an increased
risk of atrial arrhythmias in the postoperative period. The
bicaval technique is more complicated and, therefore,
might require a longer operation times. However, the
bicaval technique leads to improved hemodynamics and
a lower incidence of atrial arrhythmias in the post-
operative period.6,7 Unfortunately, most reported studies
are insufficiently powered to detect important differ-
ences. Therefore, a systematic review and meta-analysis
was conducted to assess the possible advantages in
early and late posttransplantation outcomes in patients
who underwent biatrial OHT compared with bicaval
OHT.The Supplemental Material can be viewed in the
online version of this article [http://doi.org/10.1016/j.
athoracsur.2019.12.048] on http://www.annalsthoracic
surgery.org.
0003-4975/$36.00
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Search Strategy
To establish an overview of reported outcome, a sys-
tematic literature search, according to the PRISMA
(Preferred Reporting Items for Systematic Reviews and
Meta-Analysis) guidelines, was conducted (Supplemental
Text 1).8 Search terms were developed in collaboration
with a dedicated librarian in our center. On December 15,
2017, Embase, MEDLINE, Cochrane, Web of Science, and
Google Scholar were searched (search terms are provided
in Supplemental Text 2). Inclusion and exclusion criteria
were defined a priori. Randomized controlled trials and
observational studies concerning adult patients under-
going OHT comparing the standard biatrial OHT and the
bicaval OHT were included. Studies with less than 20
patients, poster publications, abstracts, and conference
summaries were excluded. Studies with less than 20 pa-
tients were excluded because these studies were most
likely early experiential series and do not reflect the
general population. Posters and abstracts were not
included because these formats did not undergo exten-
sive peer reviewing. In the case of overlapping study
populations, the study with the most patient-years of
follow-up were selected. Exceptions were made for
studies that reported on more outcomes of interest.
Furthermore, non-English studies were excluded. Two
researchers (C.F.Z. and K.M.V.) independently reviewed
abstracts and full texts in an unblinded standardized
manner. In case of disagreement to include a study, an
agreement was negotiated.
Data Extraction
Study design, year of surgery, and follow-up (patient-
years and mean) were documented. If follow-up was not
provided, patient-years were calculated by multiplying
the number of patients with the mean follow-up (or me-
dian if the mean was not provided). The baseline char-
acteristics extracted from the individual studies are
displayed in Supplemental Table 1. In addition, the
following procedural characteristics were extracted: car-
diopulmonary bypass time, aortic cross-clamp time,
length of hospital stay, and ischemic time. The following
posttransplantation outcomes were extracted and docu-
mented as early (in-hospital or <30 day[s]) or late (out-of-
hospital or >30 days): mortality, tricuspid regurgitation,
mitral regurgitation, and pacemaker implantation. The
length of hospital stay was defined as the day the patient
received the OHT till the day the patient was dismissed
from the hospital after the transplant. The individual
study definitions were used to define the outcomes. Data
were independently extracted by 2 authors (C.F.Z. and
T.S.). The Newcastle–Ottawa Scale was used to assess the
methodological quality of the studies.9
Statistical Analyses
Log-transformed inverse variance–weighted pooled
baseline characteristics were calculated. To compare
baseline and procedural characteristics, in cases of
descriptive data, odds ratios (ORs) were used, and incases of categorical data, mean differences were used.
The ORs and mean differences were calculated with the
use of a fixed-effects model, as the goal was to compute
comparisons for the identified population, and not to
generalize to other populations, and an assessment of
baseline characteristics similar in most cases.10 A P value
less than .05 was considered statistically significant and a
95% confidence interval (CI) was calculated. Continuous
data were presented as mean with 95% CI and discrete
variables were presented as percentage with 95% CI.
Random-effects models using the DerSimonian-Laird
method were used to pool outcomes.11 ORs were used
for dichotomous data for early outcomes, and rate ratios
(RRs) were used for dichotomous data for late outcomes.
The Cochrane Q statistic and I2 were used to assess het-
erogeneity. Egger’s test and funnel plots were used to
assess the risk of publication bias.12 Comprehensive
Meta-Analysis v2.2.064 (Biostat, Engelwood, NJ) was used
to calculate the pooled outcomes and to generate forest
and funnel plots. Patient survival was visualized in a
pooled Kaplan-Meier (KM) curve derived from the orig-
inally published KM curves using the method described
by Guyot and colleagues.13 The Engauge Digitizer v10.014
was used to create a list of coordinates of the KM curve,
and an algorithm written in R (version 3.3.3; R Foundation
for Statistical Computing, Vienna, Austria) was employed
to reconstruct the original patient data. Thereafter,
GraphPad Prism version 7.00 for Windows (GraphPad
Software, San Diego, CA) was used to plot the pooled KM
curve. The reconstructed data were used to obtain hazard
ratios (HRs) of late mortality in the biatrial and bicaval
groups by univariable Cox regression. Thereafter, the
HRs were pooled using Comprehensive Meta-Analysis.
In order to evaluate whether studies before the year
2000 yielded different conclusions compared with
contemporary studies, a subgroup analysis was
performed.Results
The literature search resulted in 3648 studies, of which 45
articles met the inclusion criteria. Owing to overlapping
data, 9 studies had to be excluded, resulting in 36 in-
clusions for the meta-analysis (Figure 1). References are
represented together with the baseline characteristics of
all individual studies in Supplemental Table 1 (Refer-
ences S1-S36). The meta-analysis included 6763 patients
who had underwent OHT, of whom 3555 (52.6%) received
a biatrial OHT and 3208 (47.4%) received a bicaval OHT.
The median year of operation in the biatrial group was
1996 (range, 1988-2005) and in the bicaval group was 1998
(range: 1990-2005). Of the 36 studies, 32 were observa-
tional studies and 4 studies were randomized (References
S1, S4, S14, and S17 in Supplemental Table 1). The biatrial
group contained 1911 patients who had reported a mean
follow-up time of 6.2  8.8 years, encompassing 11,833
patient-years. The bicaval group contained 1935 patients
who had reported a mean follow-up time of 6.5  10.2
years, encompassing 12,601 patient-years. All studies
scored between 5 and 9 points on the Newcastle–Ottawa
Figure 1. Flowchart of included studies in the meta-analysis.
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(Supplemental Table 1).
Baseline and Procedural Characteristics
Pooled baseline and procedural characteristics of the 6763
patients included in the meta-analysis are shown in
Table 1.Table 1. Pooled Baseline and Procedural Characteristics of Includ
Variable Biatrial (n ¼ 3555) Bicaval (n ¼ 32
Age, ya 50.5 (50.0-51.0) 50.3 (49.8-50.8)
Male, %b 82.6 (81.0-84.2) 77.6 (75.6-79.5)
Systolic PAP, mm Hga 40.7 (38.8-42.6) 41.7 (39.6-43.8)
CVP, mm Hga 5.37 (5.10-5.63) 3.48 (3.22-3.75)
Ischemic etiology, %b 39.5 (37.1-41.9) 36.8 (34.2-39.5)
Diabetes, %b 29.6 (25.5-34.1) 26.6 (22.2-31.6)
CPB, mina 116.5 (103.3-129.6) 126.8 (111.0-142
Aortic cross-clamp time, mina 64.7 (53.3-76.1) 75.0 (58.5-91.6)
Ischemia time, mina 164.7 (162.8-166.6) 174.8 (165.8-183
Length of hospital stay, da 26.2 (19.3-33.2) 25.1 (17.4-32.9)
aMD bOR
Values are median (interquartile range).
CI, confidence interval; CPB, cardiopulmonary bypass time; CVP, central veno
pressure.Early Outcomes
A forest plot containing the individual and pooled ORs
for the early outcomes of mortality, tricuspid regurgi-
tation, mitral regurgitation, and pacemaker implanta-
tion is presented in Figures 2A to 2D. The pooled early
mortality in the biatrial group was 12.5% (95% CI, 8.3%-
18.4%) and in the bicaval group was 8.8% (95% CI, 4.8%-
15.5%), with an OR of 1.47 (95% CI, 1.0-2.2; P ¼ .048).
Furthermore, early moderate-to-severe tricuspid regur-
gitation, early moderate-to-severe mitral regurgitation,
and need of early pacemaker implantation were
observed more frequently in the biatrial OHT group
(Table 2).Late Outcomes
The meta-analyses contained 10 studies (References S13,
S14, S18, S21, S22, S26, S27, S32, S33, and S36 in Sup-
plemental Table 1) that reported KM curves that could be
pooled. The KM curves showed differences in late mor-
tality between the biatrial and bicaval groups (Figure 3).
The 2-year, 5-year, and 10-year survival rates were 80.0%
 0.1%, 71.0%  0.1%, and 60.1%  0.2% in the biatrial
group and 84.3%  0.01%, 76.8%  0.1%, and 71.2% 
0.2% in the bicaval group, respectively. Pooled HR for late
mortality showed a significantly higher risk in the biatrial
group, with an HR of 1.32 (95% CI, 1.1-1.6; P ¼ .008) and
an I2 of 38.0%. The linearized occurrence rates of late
outcomes of the individual transplant groups are pre-
sented in Table 2. Data on late tricuspid regurgitation
were reported in 8 studies and showed a significant dif-
ference in favor of the bicaval group, with a linearized
occurrence RR of 2.14 (95% CI, 1.17-3.94; P ¼ .014) (Sup-
plemental Figure 1A). Late mitral regurgitation was re-
ported in 6 studies, with a linearized occurrence RR of
1.23 (95% CI, 0.64-2.37; P ¼ .528) (Supplemental
Figure 1B). Late pacemaker implantation was reported in
8 studies and had a linearized occurrence RR of 1.93 (95%
CI, 0.92-4.10; P ¼ .083) (Supplemental Figure 1C).ed Studies
08) OR/MD (95% CI) P Value Studies Reported I2 (%)
–0.63 (–1.42 to 0.16) .118 23 54.0
1.31 (1.12 to 1.55) .002 27 47.8
–1.64 (–4.55 to 1.28) .272 6 48.0
1.01 (0.62 to 1.41) <.001 9 76.6
1.10 (0.94 to 1.28) .245 19 0.0
1.10 (0.79 to 1.52) .573 5 52.9
.5) –9.90 (–21.7 to 1.9) .099 11 90.2
–10.15 (–20.8 to 0.5) .062 6 93.4
.9) –16.7 (–27.7 to –4.3) .007 25 93.8
1.07 (–2.82 to 4.95) .590 7 70.0
us pressure; MD, mean difference; OR, odds ratio; PAP, pulmonary artery
Figure 2. Forest plots of (A) early mortality, (B) moderate-to-severe tricuspid regurgitation (TR), (C) moderate-to-severe mitral regurgitation
(MR), and (D) permanent pacemaker (PM) implantation. CI, confidence interval.
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Subgroup analysis of the 4 randomized controlled
trials was only possible for early permanent pace-
maker implantation, as other outcomes were reported
in less than 3 individual studies and no pooling
attempt was made. Early permanent pacemaker im-
plantation was comparable in these 3 studies. Sub-
group analysis of the observational studies did not
lead to a change in significance in any of the outcomes.Subgroup analyses of studies published before and
after year 2000 did not lead in changes in significance
in any of the outcomes.
Publication Bias and Sensitivity Analysis
Early and late outcomes did not show publication bias
according to Egger’s test. Funnel plots are presented
in Supplemental Figures 2A to 2D for early outcomes
and Supplemental Figures 3A to 3C for late outcomes.
Figure 2. (continued).
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significance of all outcomes.Comment
This systematic review and meta-analysis shows that the
bicaval technique is associated with superior early and
late survival, less early and late tricuspid regurgitation,
less early mitral regurgitation, and reduced early need of
permanent pacemaker implantation.
Although bicaval OHT can be considered the prefer-
able technique to perform an OHT, there are still many
centers worldwide where the biatrial approach ispreferred.15 More than a decade ago, Schnoor and col-
leagues6 performed a meta-analysis and concluded that
early outcomes in the bicaval technique have beneficial
effects in comparison with the biatrial technique. More
recent overviews of the literature have presented
similar conclusions.16,17 However, little is known about
the difference between these 2 techniques with regard
to late outcomes.6 Our meta-analysis confirms the as-
sociation of the bicaval technique with better outcomes
in the short term. Moreover, this meta-analysis, with
novel contemporary statistics, shows clinically relevant
beneficial effects of the bicaval technique in the long
term as well.
Table 2. Pooled Early and Late Outcomes
Outcome Variable Biatrial (n ¼ 3555) Bicaval (n ¼ 3208) OR/RR (95% CI) P Value Studies Reported I2 (%)
Early Mortality 12.5 (8.30 to 18.4) 8.80 (4.8 to 15.5) 1.47 (1.0 to 2.2)a .048 10 4.7
Tricuspid regurgitation 42.8 (30.8 to 55.7) 28.5 (20.2 to 38.6) 1.92 (1.4 to 2.7)a <.001 13 52.6
Mitral regurgitation 11.1 (3.6 to 29.7) 6.9 (2.4 to 17.9) 2.13 (1.3 to 3.5)a .002 6 12.1
Pacemaker implantation 19.2 (12.2 to 28.7) 8.6 (4.8 to 15.0) 2.49 (1.5 to 4.2)a .001 14 34.8
Late Mortality 4.9 (1.1 to 8.7) 4.1 (0.3 to 7.8) 1.77 (1.2 to 2.6)b .004 4 0
Tricuspid regurgitation 6.3 (3.9 to 8.6) 1.2 (0.5 to 2.0) 2.14 (1.2 to 3.9)b .014 8 79.5
Mitral regurgitation 0.4 (–0.4 to 1.3) 0.4 (–0.3 to 1.0) 1.23 (0.6 to 2.4)b .528 6 0
Pacemaker implantation 3.3 (1.3 to 5.4) 1.4 (2.0 to 2.5) 1.93 (0.9 to 4.1)b .083 8 41.5
aOR; bRR.
Values are % (95% CI) for early outcomes and linearized occurrence rate as percentage per patient year (95% CI) for late outcomes.
CI, confidence interval; OR, odds ratio; RR; rate ratio.
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There was a significant difference in the ischemia time
between the 2 transplanted groups. Although statistically
different, the absolute time difference was only 10 mi-
nutes. Cardiopulmonary bypass time and aortic cross-
clamp time did not differ significantly. The prolonged
ischemia time could be explained by the duration of
transport or waiting time before or during the operation.
In a retrospective study, Russo and colleagues18 reviewed
ischemia time in 33,640 OHT recipients in the United
Network for Organ Sharing (UNOS) database performed
between 1987 and 2004 and found no difference in long-
term survival (10 years) between prolonged ischemia
time (3.50-5.49 hours) and limited ischemia time (0.00-3.49
hours). Taking these observations into account, it seems
implausible that a 10-minute difference would lead to
major changes in postoperative outcomes. Nevertheless,
as in some selected cases, such as in reoperative heart
transplantation or abnormal caval veins, a biatrial
approach may still be preferred.
Mortality
A significant difference was found in both early mortality
and late survival between the 2 transplanted groups in
favor of the bicaval group. Davies and colleagues19
reviewed the UNOS database data between 1997 and 2007
and reported a higher survival rate in the bicaval vs
biatrial group after 10 years (57.4% vs 51.1%). The survival
rate in the present meta-analysis is higher when
compared with Davies and colleagues (71.2% vs 60.1%).19
This could be due to the fact that Davies and colleagues19
used the UNOS database, whereas the individual studies
in this meta-analysis mostly reviewed their own patients.
Thereby, a strong improvement of the posttransplant care
has been seen in the last decade, which has resulted in
increased long-term survival.20 However, both our meta-
analysis and the registry study provide a higher survival
rate in the bicaval group after 10 years of follow-up.
Tricuspid Regurgitation
This study shows a significant difference in early and late
tricuspid regurgitation in favor of the bicaval group.
Moderate-to-severe tricuspid regurgitation isusually causedby donor-recipient size mismatch, right ventricular failure
due to pretransplant pulmonary hypertension, and right
ventricular dysfunction due to donor heart rejections.21 The
cause of donor-recipient size mismatch is mainly a problem
of the atria, and the biatrial technique may induce tricuspid
regurgitation due to changes in atrial geometry. The bicaval
technique only uses the left atrium and both caval veins to
perform the anastomosis and, therefore, the technique may
prevent tricuspid regurgitation.3 Moreover, moderate-to-
severe tricuspid regurgitation after OHT could also been
caused by torn leaflets and ruptured chordae due to
surveillance endomyocardial biopsies in the years after
transplantation.22,23 It has been shown that patients with no
or mild tricuspid regurgitation have better survival than do
those with moderate or severe tricuspid regurgitation.24
Moderate-to-severe tricuspid regurgitation was, as
confirmedbyouranalysis, reportedmoreoften in thebiatrial
group and therefore could have contributed to a higher
mortality rate in this group.25-27 However, the optimal
treatment of posttransplant severe tricuspid regurgitation is
very cumbersome and still not well defined. Generally,
because severe tricuspid regurgitation remains asymptom-
atic for a long time, it is not unusual that conservative treat-
ment ispreferred to surgical treatment, probablymissing the
optimal timingof tricuspid surgery.28Therefore, reductionof
occurrence of tricuspid regurgitation by bicaval OHTmight
be a suitable approach for this post-OHT problem.
Mitral Regurgitation
Mitral regurgitation post OHT is still not well studied.
Mitral regurgitation could be caused by a mismatch in
size between the donor heart and native heart, early
allograft rejection, left ventricular failure after OHT, and a
dilated left atrium.29-31 In our study, early mitral
regurgitation occurred more frequently in the biatrial
transplant group (Figure 2D). However, in late outcomes,
no mitral regurgitation was observed. The treatment of
mitral regurgitation depends on the severity and
symptoms of the patients. Symptomatic severe mitral
regurgitation is associated with excess mortality and
frequent heart failure.32,33 Despite these poor outcomes,
only a minority of the affected patients undergo some
kind of treatment.32
Figure 3. Pooled Kaplan-
Meier curve of patient
survival after bicaval (red)
or biatrial (green) heart
transplantation.
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EarlyafterOHT,sinusnodedysfunctionandatrioventricular
conduction abnormalities are frequently encountered, with
some cases inneedof permanent pacemaker implantation.34
Increased ischemic time, a higher donor age, frequent epi-
sodesof rejection, and theanatomyof thebloodsupply to the
sinoatrial node are denoted as causes of sinus node and
atrioventricular conduction abnormalities after OHT.35-39
However, the most commonly stated cause is surgical
trauma at time of transplantation.40 Our systematic review
and meta-analysis confirms this hypothesis, showing a sig-
nificant decrease in requirement of early permanent pace-
maker implantation in the bicaval group. This is in line with
the retrospective study of Davies and colleagues19 that
showed a higher early pacemaker implantation risk in pa-
tients who underwent the biatrial OHT vs bicaval OHT after
discharge from thehospital (5.1%vs. 1.9%).AlthoughDavies
and colleagues19 also found a higher rate of late pacemaker
implantation in the biatrial group, this could not be
confirmed in thepresent study.Thismaybeexplainedby the
fact that only a few studies reported late permanent pace-
maker implantation, resulting in insufficientpower toshowa
difference.Another explanation couldbe that thedifferences
in pacemaker implantation are only presented in the early
postoperative period and become comparable with a longer
follow-up period. This was also observed by Herre and col-
leagues,34 who noted comparable findings to this meta-
analysis.
Strengths and Limitations
The majority of studies were retrospective in nature,
which made them prone to selection bias.41 This wasconfirmed by the fact that most studies scored 6 points
on the Newcastle–Ottawa Scale and no points on
comparability. Publication bias may have led to an
underestimation of the pooled estimates when studies
with relatively poor outcomes are not published.
However, funnel plots and the Egger’s test found no
indication for the presence of publication bias.
Notwithstanding, some publication bias may be present
based on visual inspection of the funnel plots. There
was moderate-to-substantial heterogeneity between
studies in most outcomes, which may potentially have
led to inaccurate results. Another limitation was caused
by the limited availability of posttransplant clinical data
about the number and severity of rejections and cardiac
transplant vasculopathy in the 2 groups, as these factors
are known to influence the long-term prognosis.
Furthermore, studies over a large time span were
included in the meta-analysis. Nevertheless, subgroup
analyses yielded comparable outcomes of both older
and contemporary studies.
Conclusion
This systematic review with meta-analysis provides
ample evidence that bicaval OHT is associated with better
early and late clinical outcomes, including early and late
survival, prevention of tricuspid regurgitation, and need
of permanent pacing.
The authors thankWichor M. Bramer for his help in developing a
search strategy.
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